Fig. 1From: ARID1A genomic alterations driving microsatellite instability through somatic MLH1 methylation with response to immunotherapy in metastatic lung adenocarcinoma: a case reportDisease response. a Partial response by Response Evaluation Criteria in Solid Tumors (in cancer immunotherapy trials) after 7 cycles of nivolumab, with disappearance of right adrenal metastasis and reduction of left suprarenal mass. b New metastasis at the right deltoid muscle (confirmed progressive disease by Response Evaluation Criteria in Solid Tumors, in cancer immunotherapy trials), vanishing on cisplatin plus pemetrexed rechallenge. Blue arrow points to right adrenal metastasis. Red arrow points to left adrenal metastasis. Yellow arrow points to right deltoid muscle metastasisBack to article page